Why the study?
Does fibrinolytic therapy improve echocardiographic findings in a patient with dilated cardiomyopathy and massive right atrial/pulmonary artery thromboemboli?
Does fibrinolytic therapy improve echocardiographic findings in a patient with dilated cardiomyopathy and massive right atrial/pulmonary artery thromboemboli?
This case highlights the utility of transoesophageal echocardiography in diagnosing and monitoring the resolution of right intracavitary masses and pulmonary thromboemboli following fibrinolytic therapy.
Answers are grounded in this paper and cite their sources.
Fibrinolytic therapy may resolve thromboemboli and normalize LV function in this case; leaves open efficacy and safety in dilated cardiomyopathy with massive thrombi.
In this paper, we report a case of dilated cardiomyopathy with right atrial thrombi and pulmonary artery thromboemboli, in which regression of thromboemboli followed fibrinolytic therapy, and normalization of left ventricular dimensions and function were documented at echocardiographic follow-up. The important role of transoesophageal echocardiography in diagnosis and follow-up of right intracavitary masses and thromboemboli in the main pulmonary arteries is discussed, as is the role of echocardiography in follow-up of cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Dall'Aglio et al. (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: